128 related articles for article (PubMed ID: 15113415)
1. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.
Arapshian A; Bertran S; Kuppumbatti YS; Nakajo S; Mira-y-Lopez R
Mol Cancer; 2004 Apr; 3():13. PubMed ID: 15113415
[TBL] [Abstract][Full Text] [Related]
2. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.
Farias EF; Ong DE; Ghyselinck NB; Nakajo S; Kuppumbatti YS; Mira y Lopez R
J Natl Cancer Inst; 2005 Jan; 97(1):21-9. PubMed ID: 15632377
[TBL] [Abstract][Full Text] [Related]
3. Cellular retinol-binding protein expression and breast cancer.
Kuppumbatti YS; Bleiweiss IJ; Mandeli JP; Waxman S; Mira-Y-Lopez R
J Natl Cancer Inst; 2000 Mar; 92(6):475-80. PubMed ID: 10716965
[TBL] [Abstract][Full Text] [Related]
4. CRBP suppresses breast cancer cell survival and anchorage-independent growth.
Kuppumbatti YS; Rexer B; Nakajo S; Nakaya K; Mira-y-Lopez R
Oncogene; 2001 Nov; 20(50):7413-9. PubMed ID: 11704871
[TBL] [Abstract][Full Text] [Related]
5. Comparative epigenomics of human and mouse mammary tumors.
Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid.
Wei LN; Blaner WS; Goodman DS; Nguyen-Huu MC
Mol Endocrinol; 1989 Mar; 3(3):454-63. PubMed ID: 2546063
[TBL] [Abstract][Full Text] [Related]
7. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
8. Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization.
Farias EF; Marzan C; Mira-y-Lopez R
Oncogene; 2005 Feb; 24(9):1598-606. PubMed ID: 15608670
[TBL] [Abstract][Full Text] [Related]
9. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer.
Pasquali D; Bellastella A; Valente A; Botti G; Capasso I; del Vecchio S; Salvatore M; Colantuoni V; Sinisi AA
Eur J Endocrinol; 1997 Oct; 137(4):410-4. PubMed ID: 9368510
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
12. Cellular retinoic acid- and cellular retinol-binding proteins: complementary deoxyribonucleic acid cloning, chromosomal assignment, and tissue specific expression.
Wei LN; Mertz JR; Goodman DS; Nguyen-Huu MC
Mol Endocrinol; 1987 Aug; 1(8):526-34. PubMed ID: 2856408
[TBL] [Abstract][Full Text] [Related]
13. Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins.
Doldo E; Costanza G; Agostinelli S; Tarquini C; Ferlosio A; Arcuri G; Passeri D; Scioli MG; Orlandi A
Biomed Res Int; 2015; 2015():624627. PubMed ID: 25879031
[TBL] [Abstract][Full Text] [Related]
14. Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.
Tanioka M; Mott KR; Hollern DP; Fan C; Darr DB; Perou CM
Genome Med; 2018 Nov; 10(1):86. PubMed ID: 30497520
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
17. Cellular retinol binding protein 1 transfection reduces proliferation and AKT-related gene expression in H460 non-small lung cancer cells.
Ferlosio A; Doldo E; Agostinelli S; Costanza G; Centofanti F; Sidoni A; Orlandi A
Mol Biol Rep; 2020 Sep; 47(9):6879-6886. PubMed ID: 32909215
[TBL] [Abstract][Full Text] [Related]
18. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.
Farias EF; Arapshian A; Bleiweiss IJ; Waxman S; Zelent A; Mira-Y-Lopez R
Cell Growth Differ; 2002 Aug; 13(8):335-41. PubMed ID: 12193472
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer.
Lo PK; Mehrotra J; D'Costa A; Fackler MJ; Garrett-Mayer E; Argani P; Sukumar S
Cancer Biol Ther; 2006 Mar; 5(3):281-6. PubMed ID: 16410723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]